Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice
- PMID: 17540175
- DOI: 10.1016/j.cell.2007.03.051
Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice
Abstract
Ras proteins signal through direct interaction with a number of effector enzymes, including type I phosphoinositide (PI) 3-kinases. Although the ability of Ras to control PI 3-kinase has been well established in manipulated cell culture models, evidence for a role of the interaction of endogenous Ras with PI 3-kinase in normal and malignant cell growth in vivo has been lacking. Here we generate mice with mutations in the Pi3kca gene encoding the catalytic p110alpha isoform that block its interaction with Ras. Cells from these mice show proliferative defects and selective disruption of signaling from growth factors to PI 3-kinase. The mice display defective development of the lymphatic vasculature, resulting in perinatal appearance of chylous ascites. Most importantly, they are highly resistant to endogenous Ras oncogene-induced tumorigenesis. The interaction of Ras with p110alpha is thus required in vivo for certain normal growth factor signaling and for Ras-driven tumor formation.
Comment in
-
Stopping ras in its tracks.Cell. 2007 Jun 1;129(5):855-7. doi: 10.1016/j.cell.2007.05.031. Cell. 2007. PMID: 17540164
Similar articles
-
Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation.EMBO J. 1996 May 15;15(10):2442-51. EMBO J. 1996. PMID: 8665852 Free PMC article.
-
Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.Oncogene. 2008 Jul 3;27(29):4096-106. doi: 10.1038/onc.2008.40. Epub 2008 Mar 3. Oncogene. 2008. PMID: 18317450
-
Functional inhibition of PI3K by the betaGBP molecule suppresses Ras-MAPK signalling to block cell proliferation.Oncogene. 2007 Dec 6;26(55):7709-14. doi: 10.1038/sj.onc.1210580. Epub 2007 Jul 2. Oncogene. 2007. PMID: 17603562
-
Role of RAS in the regulation of PI 3-kinase.Curr Top Microbiol Immunol. 2010;346:143-69. doi: 10.1007/82_2010_56. Curr Top Microbiol Immunol. 2010. PMID: 20563706 Review.
-
A genetically defined normal human somatic cell system to study ras oncogenesis in vivo and in vitro.Methods Enzymol. 2006;407:637-47. doi: 10.1016/S0076-6879(05)07050-3. Methods Enzymol. 2006. PMID: 16757358 Review.
Cited by
-
EPHB4-RASA1 Inhibition of PIEZO1 Ras Activation Drives Lymphatic Valvulogenesis.Circ Res. 2024 Nov 8;135(11):1048-1066. doi: 10.1161/CIRCRESAHA.124.325383. Epub 2024 Oct 18. Circ Res. 2024. PMID: 39421925
-
Mediating kinase activity in Ras-mutant cancer: potential for an individualised approach?Front Pharmacol. 2024 Sep 20;15:1441938. doi: 10.3389/fphar.2024.1441938. eCollection 2024. Front Pharmacol. 2024. PMID: 39372214 Free PMC article. Review.
-
The Role of Inositols in Endocrine and Neuroendocrine Tumors.Biomolecules. 2024 Aug 14;14(8):1004. doi: 10.3390/biom14081004. Biomolecules. 2024. PMID: 39199391 Free PMC article. Review.
-
When, where and which PIK3CA mutations are pathogenic in congenital disorders.Nat Cardiovasc Res. 2022 Aug;1(8):700-714. doi: 10.1038/s44161-022-00107-8. Epub 2022 Aug 8. Nat Cardiovasc Res. 2022. PMID: 39196083 Review.
-
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer.Signal Transduct Target Ther. 2024 Aug 21;9(1):205. doi: 10.1038/s41392-024-01907-z. Signal Transduct Target Ther. 2024. PMID: 39164274 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous